Request Sample Inquiry
Genomic Biomarkers Market

Genomic Biomarkers Market

Genomic Biomarkers Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

148

Base Year:

2022

Date

Aug - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2234

Segments Covered
  • By Type By Type Predictive Biomarkers, Prognostic Biomarkers
  • By Disease Indication By Disease Indication Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
  • By Validation By Validation Analytical Validation, Clinical Validation, Clinical Utility
  • By End User By End User Hospitals, Diagnostic Centers, Research Laboratories, Other End Users
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 3.7 Billion
Revenue 2030Revenue 2030: USD 8.6 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 12.9%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. Global Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. Global Genomic Biomarkers Market - by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. Global Genomic Biomarkers Market - by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. Global Genomic Biomarkers Market - by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. Global Genomic Biomarkers Market - by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. Global Genomic Biomarkers Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. North America Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. North America Genomic Biomarkers Market, by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. North America Genomic Biomarkers Market, by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. North America Genomic Biomarkers Market, by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. North America Genomic Biomarkers Market, by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. North America Genomic Biomarkers Market, by Country
      1. U.S.
        1. U.S. Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. U.S. Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. U.S. Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. U.S. Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      2. Canada
        1. Canada Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Canada Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Canada Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Canada Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      3. Mexico
        1. Mexico Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Mexico Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Mexico Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Mexico Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
  5. Europe Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. Europe Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. Europe Genomic Biomarkers Market, by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. Europe Genomic Biomarkers Market, by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. Europe Genomic Biomarkers Market, by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. Europe Genomic Biomarkers Market, by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. Europe Genomic Biomarkers Market, by Country
      1. Germany
        1. Germany Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Germany Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Germany Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Germany Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      2. UK
        1. UK Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. UK Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. UK Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. UK Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      3. France
        1. France Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. France Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. France Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. France Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      4. Spain
        1. Spain Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Spain Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Spain Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Spain Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      5. Italy
        1. Italy Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Italy Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Italy Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Italy Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      6. BENELUX
        1. BENELUX Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. BENELUX Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. BENELUX Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. BENELUX Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      7. Rest of Europe
        1. Rest Of Europe Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Rest Of Europe Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Rest Of Europe Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Rest Of Europe Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
  6. Asia Pacific Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. Asia Pacific Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Genomic Biomarkers Market, by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. Asia Pacific Genomic Biomarkers Market, by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. Asia Pacific Genomic Biomarkers Market, by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. Asia Pacific Genomic Biomarkers Market, by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. Asia Pacific Genomic Biomarkers Market, by Country
      1. China
        1. China Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. China Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. China Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. China Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      2. Japan
        1. Japan Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Japan Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Japan Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Japan Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      3. India
        1. India Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. India Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. India Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. India Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      4. South Korea
        1. South Korea Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. South Korea Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. South Korea Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. South Korea Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      5. South East Asia
        1. South East Asia Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. South East Asia Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. South East Asia Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. South East Asia Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Rest of Asia Pacific Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Rest of Asia Pacific Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Rest of Asia Pacific Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
  7. Latin America Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. Latin America Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. Latin America Genomic Biomarkers Market, by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. Latin America Genomic Biomarkers Market, by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. Latin America Genomic Biomarkers Market, by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. Latin America Genomic Biomarkers Market, by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. Latin America Genomic Biomarkers Market, by Country
      1. Brazil
        1. Brazil Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Brazil Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Brazil Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Brazil Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      2. Argentina
        1. Argentina Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Argentina Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Argentina Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Argentina Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      3. Rest of Latin America
        1. Rest of Latin America Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Rest of Latin America Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Rest of Latin America Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Rest of Latin America Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
  8. Middle East & Africa Genomic Biomarkers Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Genomic Biomarkers Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Genomic Biomarkers Market, by Type
      1. By Predictive Biomarkers
      2. By Prognostic Biomarkers
    4. Middle East & Africa Genomic Biomarkers Market, by Disease Indication
      1. By Oncology
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Renal Disorders
      5. By Other Disease Indications
    5. Middle East & Africa Genomic Biomarkers Market, by Validation
      1. By Analytical Validation
      2. By Clinical Validation
      3. By Clinical Utility
    6. Middle East & Africa Genomic Biomarkers Market, by End User
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Research Laboratories
      4. By Other End Users
    7. Middle East & Africa Genomic Biomarkers Market, by Country
      1. GCC Countries
        1. GCC Countries Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. GCC Countries Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. GCC Countries Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. GCC Countries Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      2. South Africa
        1. South Africa Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. South Africa Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. South Africa Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. South Africa Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Genomic Biomarkers Market, By Type
          1. By Predictive Biomarkers
          2. By Prognostic Biomarkers
        2. Rest of Middle East & Africa Genomic Biomarkers Market, By Disease Indication
          1. By Oncology
          2. By Cardiovascular Diseases
          3. By Neurological Diseases
          4. By Renal Disorders
          5. By Other Disease Indications
        3. Rest of Middle East & Africa Genomic Biomarkers Market, By Validation
          1. By Analytical Validation
          2. By Clinical Validation
          3. By Clinical Utility
        4. Rest of Middle East & Africa Genomic Biomarkers Market, By End User
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Research Laboratories
          4. By Other End Users
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Thermo Fisher Scientific Inc. (U.S.)
    2. F. Hoffmann-La Roche AG (Switzerland)
    3. QIAGEN (Germany)
    4. Bio-Rad Laboratories Inc. (U.S.)
    5. Myriad Genetics Inc. (U.S.)
    6. Eurofins Scientific (Luxembourg)
    7. Almac Group (UK)
    8. Agilent (U.S.)
    9. Illumina (U.S.)
    10. Pfizer Inc. (U.S.)
    11. Danaher Corp. (U.S.)
    12. Siemens Healthineers AG (Germany)
    13. Merck KGaA (Germany)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 10-Aug-2023
Genomic Biomarkers Market to Reach Valuation of USD 8.6 Billion by 2030 – Rising Demand for Personalized Medicine and Advancements in Gene Sequencing Technologies Drives the Market
FAQ
Frequently Asked Question

  • The global Genomic Biomarkers valued at USD 3.7 Billion in 2022 and is expected to reach USD 8.6 Billion in 2030 growing at a CAGR of 12.9%.

  • The prominent players in the market are Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), QIAGEN (Germany), Bio-Rad Laboratories Inc. (U.S.), Myriad Genetics Inc. (U.S.), Eurofins Scientific (Luxembourg), Almac Group (UK), Agilent (U.S.), Illumina (U.S.), Pfizer Inc. (U.S.), Danaher Corp. (U.S.), Siemens Healthineers AG (Germany), Merck KGaA (Germany).

  • The market is project to grow at a CAGR of 12.9% between 2023 and 2030.

  • The driving factors of the Genomic Biomarkers include

    • Rise in demand for personalized medicine will propel the market growth

  • North America was the leading regional segment of the Genomic Biomarkers in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy